Lilly: Put law enforcement on the online fakes case

Eli Lilly is asking law enforcement to backtrack the online counterfeit drug supply chain and shut down the sources. Getting to the source of fakes is one element of the company's brand-protection strategy.

"Dismantling counterfeit pharmaceutical networks must become a higher priority for law enforcement globally," said Michael Russo, director of global security at Eli Lilly, as in-Pharma Technologist reports.

Companies that indirectly support fake pharmacies is another of the drug giant's targets.

The article notes that Google and Go Daddy are setting up the non-profit Center for Safe Internet Pharmacies. But government support is needed to provide legal protection, allowing the center to terminate service to sites that endanger public health.

- here's the story

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.